高产量的重组腺相关病毒生产体的工程
Marco T Radukic1, Dinh To Le1, Robert Freudenberg1
1Cellular and Molecular Biotechnology, Faculty of Technology, Bielefeld University, Bielefeld, Germany.
Biotechnology journal
|January 14, 2026
概括
生产者等离子体工程显著提高了复合腺相关病毒 (rAAV) 的生产. 优化Rep基因和辅助质粒可以提高rAAV标位和基因治疗应用的质量.
科学领域:
- 分子生物学分子生物学
- 基因治疗 基因治疗
- 生物技术是生物技术.
背景情况:
- 重组腺相关病毒 (rAAV) 生产面临的挑战是满足数量和质量的需求.
- 目前的rAAV矢量生产方法,特别是HEK-293三重转化,需要优化以获得更高的产量和均性.
研究的目的:
- 研究生产者等离子体工程策略,以提高rAAV产量和同质性.
- 确定特定的基因修改,以提高RAAV载体生产效率和质量.
主要方法:
- 利用微型化生产和当天量化来简化生产塑料的研究.
- 设计了AAV2 Rep基因集群和修改预测的Rep后翻译修改站点.
- 评估了最小的辅助等离子体,并淘汰了MAAP的退出蛋白.
主要成果:
- 对AAV2 Rep基因集群的修改降低了循环包装等离子体的标位,野生类型的回归剂产生了116倍高的标位 (~10^6颗粒/细胞) 和减少了错误包装.
- 改变预测的Rep翻译后修改位点减少了空体的比例.
- 一个最小的辅助等离子体维持了AAV2的生产,但不是AAV6/AAV9.
- 淘汰MAAP增加了细胞颗粒中的rAAV产量.
结论:
- 生产者等离子体设计对于开发高位数rAAV生产系统至关重要.
- 特定的基因修改,包括Rep基因优化和MAAP淘汰,在rAAV产量和质量方面提供了显著的改进.
- 在生产者等离子体工程中存在权衡,影响不同的AAV血清型和生产特征.
相关概念视频
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...